Clinical trial
Study to Explore Safety And Tolerability of Fosamprenavir With or Without…
NCT00043888 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00043888 |
|---|---|
| Title | Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR |
| Official title | A Phase IIIb/IV, Randomized, Open Label, Multicenter, Pilot Trial to Explore the Safety and Tolerability of GW433908 +/- Ritonavir (1400mg Twice Daily or 700mg/100mg Twice Daily) When Used in Combination With a Zidovudine-containing Regimen (TRIZIVIR or COMBIVIR Twice Daily) Over a 24 Week Period in… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | fosamprenavir, COMBIVIR, ritonavir, TRIZIVIR |
| Enrollment | 60 |
| Start date | Jan 1, 2002 |
| Primary completion | May 1, 2003 |
| Completion | May 1, 2003 |
| First posted | Aug 19, 2002 |
| Last update posted | Feb 12, 2013 |
| Countries | France, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: